United States · Biotechnology startup

Sanguine

Bridging the gap between patients and researchers

Funding reportedLast round: Debt financing

BiotechnologyWoburn, United States

What company datasets say Sanguine raised

Funding, as reported

Reported in all$12Min dollars
Rounds8
Last roundDebt financing
Last round dateOct 2023
Investors listed11

On 2 portfolio pages

Investors who name them

Each firm lists Sanguine on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

Biotechnology in United States

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Sanguine in front of investors. Or tell us what we have wrong.

List your startupSend a correction